BCA
AFIB

Berman Capital Advisors’s Acutus Medical Inc AFIB Stock Holding History

Berman Capital Advisors’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-397
Closed -$6K – 2266
2021
Q2 		$6K Buy
+397
New +$5.81K ﹤0.01% 1319

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KA
Kerrisdale Advisers Miami, Florida $263M AUM 40.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return

Berman Capital Advisors's AFIB Position: Q3 2021 in Review

Berman Capital Advisors sold out of Acutus Medical Inc (AFIB) in Q3 2021, closing a stake of 397 shares — an estimated $6K sold.

Berman Capital Advisors first reported a position in AFIB in Q2 2021 and held it in 1 quarter. The position peaked at $6K in Q2 2021. 70 funds tracked by Wall St. Rank hold AFIB as of Q3 2021.

  • Berman Capital Advisors reported no remaining Acutus Medical Inc position as of Q3 2021 after selling out during the quarter.
  • Berman Capital Advisors sold 397 Acutus Medical Inc shares in Q3 2021, an estimated $6K.
  • Berman Capital Advisors first reported a position in Acutus Medical Inc in Q2 2021 and held it in 1 quarter.
  • Berman Capital Advisors's Acutus Medical Inc position peaked at $6K in Q2 2021.
  • 70 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.